Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancerE E Vokes, D J Haraf, R Mick, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesisG F Fleming, E E Vokes, J M McEvilly, et al.Journal of the National Cancer Institute|June 3, 1992
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancerE E Vokes, R R Weichselbaum, R Mick, et al.Seminars in Oncology|August 1, 1992
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancerE E Vokes, D J Haraf, R R Weichselbaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patientsL C Platanias, C B Miller, R Mick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysisE E Vokes, M J Ratain, R Mick, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approachE E Vokes, D J Haraf, J M McEvilly, et al.Pageof 1